06.12.2014 19:29:54
|
JPMorgan's CEO Dimon Says Tests Show No Evidence Of Cancer
(RTTNews) - JPMorgan Chase & Co.'s (JPM) Chairman and Chief Executive Officer Jamie Dimon, who was diagnosed with throat cancer earlier this year, said that tests showed no evidence of cancer in his body.
"This past summer, I let you know that I had been diagnosed with throat cancer. Having concluded my full treatment regimen a few months ago, I wanted to give you an update on my health. This week I had the thorough round of tests and scans that are normally done three months following treatment, including a CAT scan and a PET scan. The good news is that the results came back completely clear, showing no evidence of cancer in my body. While the monitoring will continue for several years, the results are extremely positive and my prognosis remains excellent," Dimon said in a memo to employees of the company.
In July, Dimon said he had been diagnosed with throat cancer, but he said 'condition was curable." Dimon, age 58, said the cancer was confirmed following tests such as a CAT scan, PET scan and a biopsy, but it was confined to the original site and the adjacent lymph nodes on the right side of the neck. There was also no evidence of cancer elsewhere in the body.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu JPMorgan Chase & Co.mehr Nachrichten
21.01.25 |
US banks in ‘go-mode’ under Trump, says JPMorgan executive (Financial Times) | |
21.01.25 |
US banks ‘in go-mode’ under Trump, says JPMorgan executive (Financial Times) | |
17.01.25 |
Börse New York: Dow Jones letztendlich im Plus (finanzen.at) | |
17.01.25 |
Dow Jones aktuell: Dow Jones notiert am Mittag im Plus (finanzen.at) | |
17.01.25 |
NYSE-Handel: Dow Jones zum Start fester (finanzen.at) | |
16.01.25 |
Schwache Performance in New York: Dow Jones startet mit Verlusten (finanzen.at) | |
15.01.25 |
Dow Jones 30 Industrial-Titel JPMorgan Chase-Aktie: So viel Gewinn hätte ein Investment in JPMorgan Chase von vor 3 Jahren eingefahren (finanzen.at) | |
15.01.25 |
Mittwochshandel in New York: Dow Jones zum Handelsstart auf grünem Terrain (finanzen.at) |
Analysen zu JPMorgan Chase & Co.mehr Analysen
16.01.25 | JPMorgan Chase Outperform | RBC Capital Markets | |
16.01.25 | JPMorgan Chase Halten | DZ BANK | |
16.01.25 | JPMorgan Chase Buy | UBS AG | |
15.01.25 | JPMorgan Chase Outperform | RBC Capital Markets | |
02.12.24 | JPMorgan Chase Hold | Deutsche Bank AG |
Aktien in diesem Artikel
JPMorgan Chase & Co. | 252,75 | -0,04% |